Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
---|---|
Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Name | Starting Dose | Frequency | Route |
---|---|---|---|
Abatacept | For Adult (body-weight up to 60 kg) 500 mg every 2 weeks for 3 doses, then 500 mg every 4 weeks, review treatment if no response within 6 months. | IV | |
Abatacept | For Adult (body-weight 60-100 kg) 750 mg every 2 weeks for 3 doses, then 750 mg every 4 weeks, review treatment if no response within 6 months | IV | |
Abatacept | For Adult (body-weight 101 kg and above) 1 g every 2 weeks for 3 doses, then 1 g every 4 weeks, review treatment if no response within 6 months. | IV | |
Abatacept | 125 mg once weekly, review treatment if no response within 6 months, subcutaneous dosing may be initiated with or without an intravenous loading dose consult product literature. | SC |